arrow
S

Shankar Siva

University of Melbourne
H指数:59
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oligometastatic prostate cancer in the PSMA PET era: a state-specific narrative review of emerging therapeutic strategies

寡转移性前列腺癌在PSMA PET时代:一种基于特定治疗阶段的叙事性综述新兴治疗策略

2026-10-230
OAAI
Global Disparities in the Availability and Reimbursement of Systemic Therapies for Renal Cell Carcinoma: Results of the International ARON-AID Survey

全球范围内肾细胞癌系统性治疗的可及性与报销差异:国际ARON-AID调查结果

2026-10-060
OAAI
Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era

PSMA-PET时代原发miN1前列腺癌的管理

2026-09-290
OAAI
Defining Intraprostatic Gross Tumor Volume and Micro-boosting through Consensus: A Contour-Based Modified Delphi Consensus

通过共识定义前列腺内大体肿瘤体积和微增量:一种基于轮廓的改良德尔菲共识

2026-07-290
PRE
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial

单次或多次分割立体定向消融体部放疗后联合阿替利珠单抗治疗晚期三阴性乳腺癌:一项随机II期临床试验

2026-07-270
OA
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma

动态免疫特征分析预测寡转移性肾细胞癌对放疗联合抗PD-1疗法的反应

2026-07-080
OAAI
Lymph Node Sampling Patterns and Completeness of Staging During Systematic Mediastinal Lymph Node Staging in Patients with Locally Advanced Non-Small-Cell Lung Cancer: A Post Hoc Analysis from the SEISMIC Study

局部晚期非小细胞肺癌患者系统性纵隔淋巴结分期中的淋巴结取样模式和分期完整性:SEISMIC研究的事后分析

Cancers
IF4.4
2026-05-300
OA
Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Practical Multidisciplinary Approach to Challenging Scenarios from the International Association for the Study of Lung Cancer (IASLC) Advanced Radiation Technology (ART) Subcommittee

不可切除的局部晚期非小细胞肺癌的放射治疗:国际肺癌研究协会(IASLC)高级放射技术(ART)分委会针对挑战性场景的实用多学科方法

2025-11-140
PRE
A prospective pilot study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer

一项关于在非小细胞肺癌患者放疗期间和放疗后,进行Gallium-68肺通气和灌注PET/CT的前瞻性试点研究

2025-10-100
PRE
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the Kidney

立体定向消融体部放射治疗(SABR)在不常见类型原发性肾癌中的疗效:国际肾脏放射外科肿瘤学协作组(International Radiosurgery Oncology Consortium of the Kidney)的分析

2025-09-020
PRE
Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review

立体定向体部放射治疗肾上腺转移瘤——基于病例的放射外科协会实践指南与综述

2025-07-120
OAAI
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma

R.E.N.A.L.复杂度评分对原发性肾细胞癌立体定向消融体部放射治疗效果的影响

2025-06-280
OAAI